Objetivo
Neurodegenerative (ND) and neuromuscular (NM) disease is one of the most frequent classes of rare diseases, affecting life and mobility of 500,000 patients in Europe and millions of their caregivers, family members and employers. This NEUROMICS project brings together the leading research groups in Europe, five highly innovative SMEs and relevant oversea experts using the most sophisticated Omics technologies to revolutionize diagnostics and to develop pathomechanism-based treatment for ten major ND and NM diseases. Specifically we aim to:
(i) use next generation WES to increase the number of known gene loci for the most heterogeneous disease groups from about 50% to 80%,
(ii) increase patient cohorts by large scale genotyping by enriched gene variant panels and NGS of so far unclassified patients and subsequent phenotyping,
(iii) develop biomarkers for clinical application with a strong emphasis on presymptomatic utility and cohort stratification,
(iv) combine -omics approaches to better understand pathophysiology and identify therapeutic targets,
(v) identify disease modifiers in disease subgroups cohorts with extreme age of onset
(vi) develop targeted therapies (to groups or personalized) using antisense oligos and histone deacetylase inhibitors, translating the consortiums expertise in clinical development from ongoing trials toward other disease groups, notably the PolyQ diseases and other NMD.
To warrant that advances affect a large fraction of patients we limited the selection to a number of major categories, some of which are in a promising stage of etiological and therapeutic research while some others are in great need of further classification. The efforts will be connected through a NEUROMICS platform for impact, communication and innovation that will provide tools and procedures for ensuring trial-readiness, WP performance, sustainability, interaction with the chosen Support IRDiRC and RD-Connect project and involvement of stakeholders in the NDD/NMD field.
Ámbito científico
Convocatoria de propuestas
FP7-HEALTH-2012-INNOVATION-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
72074 Tuebingen
Alemania
Ver en el mapa
Participantes (18)
2333 ZA Leiden
Ver en el mapa
50937 Koeln
Ver en el mapa
NE1 7RU Newcastle Upon Tyne
Ver en el mapa
53127 Bonn
Ver en el mapa
WC1E 6BT London
Ver en el mapa
13284 Marseille
Ver en el mapa
75654 Paris
Ver en el mapa
9052 ZWIJNAARDE - GENT
Ver en el mapa
20122 Milano
Ver en el mapa
44121 Ferrara
Ver en el mapa
CB2 1TN Cambridge
Ver en el mapa
101 Reykjavik
Ver en el mapa
20850 ROCKVILLE
Ver en el mapa
92100 BOULOGNE BILLANCOURT
Ver en el mapa
SE16494 KISTA
Ver en el mapa
6511 AA Nijmegen
Ver en el mapa
6009 Crawley
Ver en el mapa
79106 Freiburg
Ver en el mapa